Holen Sie sich die Stockscreener-App
18.87
1.26%
-0.24
Handel nachbörslich:
19.10
0.23
+1.22%
Schlusskurs vom Vortag:
$19.11
Offen:
$19.03
24-Stunden-Volumen:
3.53M
Relative Volume:
0.53
Marktkapitalisierung:
$6.55B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-277.02M
KGV:
-20.23
EPS:
-0.9328
Netto-Cashflow:
$-91.36M
1W Leistung:
+0.27%
1M Leistung:
+17.86%
6M Leistung:
+79.71%
1J Leistung:
+984.48%
1-Tages-Spanne:
$18.80
$19.96
1-Wochen-Bereich:
$18.60
$19.96
52-Wochen-Spanne:
$1.3301
$24.28
Erasca Inc Stock (ERAS) Company Profile
Firmenname
Erasca Inc
Sektor
Branche
Telefon
(858) 465-6511
Adresse
3115 MERRYFIELD ROW, SAN DIEGO
Compare ERAS vs VRTX, REGN, ARGX, RVMD, ALNY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ERAS
Erasca Inc
|
18.87 | 6.63B | 0 | -277.02M | -91.36M | -0.9328 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Erasca Inc Stock (ERAS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-27 | Fortgesetzt | Mizuho | Outperform |
| 2026-01-07 | Eingeleitet | Piper Sandler | Overweight |
| 2025-10-16 | Eingeleitet | Stifel | Buy |
| 2025-09-03 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-08-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-26 | Eingeleitet | Raymond James | Outperform |
| 2024-11-18 | Eingeleitet | Jefferies | Buy |
| 2024-03-11 | Eingeleitet | CapitalOne | Overweight |
| 2024-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-10-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-03-30 | Eingeleitet | Mizuho | Buy |
| 2023-02-24 | Eingeleitet | Goldman | Buy |
| 2023-02-03 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Erasca Inc Aktie (ERAS) Neueste Nachrichten
Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action LawsuitContact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline - StreetInsider
ERAS Shareholder Alert: August 10, 2026 Lead Plaintiff - GlobeNewswire
Erasca Inc (ERAS) Cash Flow - TradingKey
Erasca Inc (ERAS) Income Statement - TradingKey
Erasca Inc (ERAS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Erasca Inc (ERAS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Erasca Inc (ERAS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
2026-07-26 | ERAS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Erasca, Inc. to Contact the Firm Today! | NDAQ:ERAS | Press Release - Stockhouse
Erasca Inc (ERAS) Valuation: PE, PB & Fair Value Analysis - TradingKey
August 10, 2026 Deadline Approaching: Join Class Action Against Erasca, Inc. (ERAS)Contact Levi & Korsinsky - ACCESS Newswire
Erasca Inc (ERAS) Institutional Confidence - TradingKey
Levi & Korsinsky Urges Erasca, Inc. (ERAS) Shareholders to Act Before Lead Plaintiff Deadline August 10, 2026 - ACCESS Newswire
Erasca Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ErascaERAS - PR Newswire
ERASCA DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Erasca, Inc. Investors with Losses ... - Caledonian Record
ERAS Stock Slumps Nearly 40% After-Hours: Fine Print In 'Positive' Cancer Trial Reveals Treatment-Related Death - Stocktwits
Erasca, Inc. Revenue Breakdown – NASDAQ:ERAS - TradingView
Kaplan Fox Reminds Erasca, Inc. (ERAS) Investors Seeking Recovery of the Lead Plaintiff Deadline on August 10, 2026 - TMX Newsfile
ERAS INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Finansavisen
Bragar Eagel & Squire, P.C. Reminds Erasca, Inc. (ERAS) - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Erasca, Inc. (ERAS) Investors that a Class Action ... - Caledonian Record
Bragar Eagel & Squire, P.C. Reminds Erasca, Inc. (ERAS) Investors that a Class Action Lawsuit Has Been Filed Against Erasca and Encourages Investors to Contact the Firm Before August 10th - GlobeNewswire Inc.
ERAS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Deadline Alert: Erasca, Inc. (ERAS) Shareholders Who Lost - GlobeNewswire
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Lost Money on Erasca, Inc. (ERAS)? Join Class Action Suit Seeking RecoveryContact SueWallSt - Finansavisen
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: - GlobeNewswire
2026-07-23 | ERAS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Erasca, Inc. to Contact the Firm Today! | NDAQ:ERAS | Press Release - Stockhouse
ERAS Stockholders Have Opportunity to Lead Erasca, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit - Finansavisen
ERAS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
NASDAQ: ERAS CLASS ACTION NOTICE: Berger Montague Encourages Erasca, Inc. (NASDAQ: ERAS) Investors to Inquire About a Securities Fraud Class Action - Finansavisen
ERAS Deadline Alert: Levi & Korsinsky Reminds Erasca, Inc. (ERAS) Investors of Securities Class Action Deadline on August 10, 2026 - Finansavisen
ERASCA, INC. INVESTORS WITH LOSSES HAVE UNTIL AUGUST 10, - GlobeNewswire
Erasca investors face August 10 deadline in class action lawsuit - scanx.trade
ERAS INVESTOR DEADLINE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action LawsuitHBSS - Morningstar
Erasca (ERAS): Erasca Foundation files to sell 8,333 donated shares - Stock Titan
Kaplan Fox Announces a Securities Class Action Filed Against Erasca, Inc. (NASDAQ: ERAS)Lead Plaintiff Deadline is August 10, 2026 - The Globe and Mail
Erasca, Inc. (ERAS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - Morningstar
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Erasca, - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of Erasca, Inc. Investors - GlobeNewswire
ERAS Deadline Alert: The Gross Law Firm Reminds Erasca, Inc. (ERAS) Investors of Securities Class Action Deadline on August 10, 2026 - PR Newswire
ERAS Maintained by Morgan Stanley -- Price Target Raised to $21 - GuruFocus
ERAS STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Erasca (ERAS) Faces Class Action Claims, Is 21% Below Fair Value Enough? - simplywall.st
Kaplan Fox Encourages Investors of Erasca, Inc. (ERAS) Who Suffered Losses to Contact the Firm Before August 10, 2026 - TMX Newsfile
ERAS Shareholder Alert: Erasca, Inc. Securities Class Action LawsuitInvestors Should Contact Levi & Korsinsky - GlobeNewswire
2026-07-20 | ERAS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:ERAS | Press Release - Stockhouse
ERAS INVESTOR DEADLINE: Erasca, Inc. (ERAS) Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit – RGRD Law - marketscreener.com
ERAS INVESTOR DEADLINE: Erasca, Inc. (ERAS) Investors with - GlobeNewswire
Erasca Inc. Class Action Lawsuit Notice Issued - Intellectia AI
Finanzdaten der Erasca Inc-Aktie (ERAS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):